Literature DB >> 22822068

Two ATPases.

Alan E Senior1.   

Abstract

In this article, I reflect on research on two ATPases. The first is F(1)F(0)-ATPase, also known as ATP synthase. It is the terminal enzyme in oxidative phosphorylation and famous as a nanomotor. Early work on mitochondrial enzyme involved purification in large amount, followed by deduction of subunit composition and stoichiometry and determination of molecular sizes of holoenzyme and individual subunits. Later work on Escherichia coli enzyme utilized mutagenesis and optical probes to reveal the molecular mechanism of ATP hydrolysis and detailed facets of catalysis. The second ATPase is P-glycoprotein, which confers multidrug resistance, notably to anticancer drugs, in mammalian cells. Purification of the protein in large quantity allowed detailed characterization of catalysis, formulation of an alternating sites mechanism, and recently, advances in structural characterization.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22822068      PMCID: PMC3436262          DOI: 10.1074/jbc.X112.402313

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  85 in total

1.  Fluorescent probes applied to catalytic cooperativity in ATP synthase.

Authors:  Joachim Weber; Alan E Senior
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

2.  Properties of membranes from mutant strains of Escherichia coli in which the beta-subunit of the adenosine triphosphatase is abnormal.

Authors:  A E Senior; D R Fayle; J A Downie; F Gibson; G B Cox
Journal:  Biochem J       Date:  1979-04-15       Impact factor: 3.857

3.  Structural characterization of the interaction of the delta and alpha subunits of the Escherichia coli F1F0-ATP synthase by NMR spectroscopy.

Authors:  Stephan Wilkens; Dan Borchardt; Joachim Weber; Alan E Senior
Journal:  Biochemistry       Date:  2005-09-06       Impact factor: 3.162

4.  The defective proton-ATPase of uncD mutants of Escherichia coli. Two mutations which affect the catalytic mechanism.

Authors:  T M Duncan; A E Senior
Journal:  J Biol Chem       Date:  1985-04-25       Impact factor: 5.157

5.  Involvement of the "occluded nucleotide conformation" of P-glycoprotein in the catalytic pathway.

Authors:  Gregory Tombline; Alma Muharemagić; Lori Bartholomew White; Alan E Senior
Journal:  Biochemistry       Date:  2005-09-27       Impact factor: 3.162

6.  Both P-glycoprotein nucleotide-binding sites are catalytically active.

Authors:  I L Urbatsch; B Sankaran; S Bhagat; A E Senior
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

7.  Further examination of seventeen mutations in Escherichia coli F1-ATPase beta-subunit.

Authors:  A E Senior; M K al-Shawi
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

8.  Oxidative phosphorylation in Escherichia coli. Characterization of mutant strains in which F1-ATPase contains abnormal beta-subunits.

Authors:  A E Senior; L Langman; G B Cox; F Gibson
Journal:  Biochem J       Date:  1983-02-15       Impact factor: 3.857

Review 9.  F1F0-ATP synthase: development of direct optical probes of the catalytic mechanism.

Authors:  J Weber; A E Senior
Journal:  Biochim Biophys Acta       Date:  1996-07-18

10.  Tryptophan-free Escherichia coli F1-ATPase.

Authors:  S Wilke-Mounts; J Weber; E Grell; A E Senior
Journal:  Arch Biochem Biophys       Date:  1994-03       Impact factor: 4.013

View more
  14 in total

Review 1.  Control of rotation of the F1FO-ATP synthase nanomotor by an inhibitory α-helix from unfolded ε or intrinsically disordered ζ and IF1 proteins.

Authors:  Francisco Mendoza-Hoffmann; Mariel Zarco-Zavala; Raquel Ortega; José J García-Trejo
Journal:  J Bioenerg Biomembr       Date:  2018-09-28       Impact factor: 2.945

Review 2.  ATP synthase: a molecular therapeutic drug target for antimicrobial and antitumor peptides.

Authors:  Zulfiqar Ahmad; Florence Okafor; Sofiya Azim; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

3.  Substrates Control Multimerization and Activation of the Multi-Domain ATPase Motor of Type VII Secretion.

Authors:  Oren S Rosenberg; Dustin Dovala; Xueming Li; Lynn Connolly; Anastasia Bendebury; Janet Finer-Moore; James Holton; Yifan Cheng; Robert M Stroud; Jeffery S Cox
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

4.  Revealing the fate of cell surface human P-glycoprotein (ABCB1): The lysosomal degradation pathway.

Authors:  Kazuhiro Katayama; Khyati Kapoor; Shinobu Ohnuma; Atish Patel; William Swaim; Indu S Ambudkar; Suresh V Ambudkar
Journal:  Biochim Biophys Acta       Date:  2015-06-06

5.  Understanding the link between antimicrobial properties of dietary olive phenolics and bacterial ATP synthase.

Authors:  Amon Amini; Mason Liu; Zulfiqar Ahmad
Journal:  Int J Biol Macromol       Date:  2017-03-18       Impact factor: 6.953

6.  Safranal and its analogs inhibit Escherichia coli ATP synthase and cell growth.

Authors:  Mason Liu; Amon Amini; Zulfiqar Ahmad
Journal:  Int J Biol Macromol       Date:  2016-11-16       Impact factor: 6.953

7.  Functional importance of αAsp-350 in the catalytic sites of Escherichia coli ATP synthase.

Authors:  Samah Raheem; Amanda Steiner; Zulfiqar Ahmad
Journal:  Arch Biochem Biophys       Date:  2019-07-19       Impact factor: 4.013

8.  Functional importance of αIle-346 and αIle-348 in the catalytic sites of Escherichia coli ATP synthase.

Authors:  Chao Zhao; Hiba Syed; Sherif S Hassan; Vineet K Singh; Zulfiqar Ahmad
Journal:  Arch Biochem Biophys       Date:  2016-01-14       Impact factor: 4.013

Review 9.  Biological messiness vs. biological genius: Mechanistic aspects and roles of protein promiscuity.

Authors:  William M Atkins
Journal:  J Steroid Biochem Mol Biol       Date:  2014-09-12       Impact factor: 4.292

10.  Venom peptides cathelicidin and lycotoxin cause strong inhibition of Escherichia coli ATP synthase.

Authors:  Sofiya Azim; Derek McDowell; Alec Cartagena; Ricky Rodriguez; Thomas F Laughlin; Zulfiqar Ahmad
Journal:  Int J Biol Macromol       Date:  2016-02-27       Impact factor: 6.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.